Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control
Authors:
- 16 December 2003
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 57 (1) , 62-67
Abstract
Aims To study the elimination of ephedrines with reference to the International Olympic Committee (IOC) doping control cut‐off levels, following multiple dosing of over‐the‐counter decongestant preparations.Methods A double‐blind study was performed in which 16 healthy male volunteers were administered either pseudoephedrine or phenylpropanolamine in maximal recommended therapeutic doses over a 36‐h period. Urine was collected every two hours between 08:00 and 24:00 h and at 04:00 h throughout the testing period of three days. Urine drug levels were quantified using high performance liquid chromatography. Side‐effects were assessed, including heart rate and blood pressure, every four hours between 08:00 and 20:00 h.Results Mean (95% CI) total phenylpropanolamine and pseudoephedrine eliminated unchanged was 75 (88, 61) and 81 (92, 71)%, respectively. Maximum urine concentrations of phenylpropanolamine and pseudoephedrine were 112.1 (164.2, 59.9) and 148.5 (215.0, 82.1) mg.l−1, respectively. A peak in drug urine concentration occurred four hours following the final dose. There were no adverse cardiovascular effects and only mild CNS stimulation was evident.Conclusions Following therapeutic, multiple dosing, drug levels remain above the IOC cut‐off levels for a minimum of 6 h and 16 h following final doses of phenylpropanolamine and pseudoephedrine, respectively. Athletes require informed advice on this from their healthcare professionals.Keywords
This publication has 20 references indexed in Scilit:
- Urinary Excretion of Ephedrine After Nasal Application in Healthy VolunteersJournal of Pharmacy and Pharmacology, 1992
- Bioavailability and cardiovascular safety of dexatrim® (phenylpropanolamine hydrochloride) from a controlledrelease capletBiopharmaceutics & Drug Disposition, 1990
- Steady State Pharmacokinetics and Dose‐Proportionality of Phenylpropanolamine in Healthy SubjectsThe Journal of Clinical Pharmacology, 1990
- Pharmacokinetics of phenylpropanolamine in humans after a single-dose studyInternational Journal of Pharmaceutics, 1987
- Selected Cardiac and Metabolic Responses to Pseudoephedrine with ExerciseThe Journal of Clinical Pharmacology, 1981
- Stereospecific Radioimmunoassays for d-Pseudoephedrine in Human Plasma and Their Application to Bioequivalency StudiesJournal of Pharmaceutical Sciences, 1981
- Comparison of GLG and High-pressure Liquid Chromatographic methods for Analysis of Urinary PseudoephedrineJournal of Pharmaceutical Sciences, 1979
- Urinary Excretion of Chlorpheniramine and Pseudoephedrine in HumansJournal of Pharmaceutical Sciences, 1979
- Enhanced Pseudoephedrine Absorption by Concurrent Administration of Aluminum Hydroxide Gel in HumansJournal of Pharmaceutical Sciences, 1972
- Evaluation of a Sustained Release Form of Phenylpropanolamine Hydrochloride by Urinary Excretion StudiesJournal of Pharmaceutical Sciences, 1961